Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

DELFI DIAGNOSTICS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

DELFI DIAGNOSTICS

via TIBER CREEK GROUP

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 13, 2024Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: DELFI DIAGNOSTICS
Description: Life Sciences/Cancer Screening.
Location: Maryland · United States of America

Registrant

Firm: TIBER CREEK GROUP
Description: Government Relations.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Issues related to cancer screenings.
LobbyistsBRYANT HALL · COREY MALMGREN
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.